Skip to content

Hysterectomy by transumbilical laparoendoscopic single site surgery(TU-LESS) or transvaginal natural orifice transluminal endoscopic surgery(vNOTES): a randomised controlled trial

Hysterectomy by transumbilical laparoendoscopic single site surgery(TU-LESS) or transvaginal natural orifice transluminal endoscopic surgery(vNOTES): a randomised controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023242
Enrollment
Unknown
Registered
2019-05-18
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign diseases of uterus

Interventions

1:hysterectomy by transvaginal natural orifice transluminal endoscopic surgery(vNOTES)
2:transumbilical laparoendoscopic single site surgery(TU-LESS)

Sponsors

The Third Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Women aged 30–70 years, with a non-prolapsed uterus in need of a hysterectomy for benign indication.

Exclusion criteria

Exclusion criteria: History of rectal surgery, suspected rectovaginal, endometriosis or malignancy, history of pelvic inflammatory disease, active lower genital tract infection, virginity, pregnancy or failure to provide written informed consent.

Design outcomes

Primary

MeasureTime frame
The proportion of women successfully treated by removing the uterus by the intended approach without conversion to another approach;

Secondary

MeasureTime frame
postoperative pain scores measured using a VAS;the use of analgesics after surgery;postoperative infection;intraoperative or postoperative complications;readmission during the first 6 weeks of surgery;the duration of surgery (min);blood loss during surgery (ml);postoperative hospitalization days;hospitalization expense;

Countries

China

Contacts

Public ContactXingnan Zhou

The Third Affiliated Hospital of Guangzhou Medical University

xingnan.zhou@gzhmu.edu.cn+86 18820045585

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026